Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society
Article Title: The Histone Deacetylase Inhibitor Vorinostat Selectively Sensitizes Fibrosarcoma Cells to Chemotherapy
doi: 10.1002/jor.21274
Figure Lengend Snippet: Vorinostat sensitizes fibrosarcoma but not normal fibroblasts to doxorubicin. STS cells and normal fibroblasts were treated with 1.0 μM vorinostat or vehicle for 72 h. Doxorubicin was added at the beginning of the third day. (A) Representative (×200) phase-contrast and fluorescent photomicrographs of HT1080 cells plated in chamber slides, treated with vorinostat, doxorubicin, or both and then fixed and stained with anti-cleaved caspase 3 (BD Pharmingen™) and anti-rabbit Alexa Fluor® 488 (Invitrogen) antibodies. I: Phase contrast; II: cleaved caspase 3; III: doxorubicin; IV: DAPI. (B) Vorinostat and doxorubicin synergistically induce apoptosis in HT1080 but not SK-LMS-1 or SW872 STS cells, or WS-1 normal fibroblasts. After a 72-h treatment with vorinostat, doxorubicin, or both, cells were trypsinized, fixed, stained for cleaved caspase 3 and analyzed by flow cytometry. Bars represent the mean and whiskers represent the SEM of at least four biological replicates. Statistical significance is denoted by: * versus vehicle, # versus vorinostat alone, † versus doxorubicin alone.
Article Snippet: Cell Culture Human HT1080 fibrosarcoma, SK-LMS-1 leiomyosarcoma, and SW872 liposarcoma cells, and WS-1 normal human fibroblasts were obtained from the ATCC (Manassas, VA) and cultured in minimal essential media (Gibco, Life Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum (Hyclone, Logan, UT), nonessential amino acids (Gibco), sodium pyruvate (Gibco), and penicillin–streptomycin (Gibco) at 37°C under 5% CO 2 .
Techniques: Staining, Flow Cytometry